The Therapeutic Goods
Administration has added Translarna
(atalauren) and Cystadrops
(mercaptamine hydrochloride) to its
list of designated orphan drugs.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 24 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 15
LEADING pharmacy, consumer and Federal agencies want to see better use of existing funding and leverage digital health resources to improve quality use of medicines, discussions at the Medicines Safety Forum in Canberra revealed.